During the past decade, Norton Cancer Institute, St Matthews Campus conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 4 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 4 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Norton Cancer Institute, St Matthews Campus" #1 sponsor was "Pfizer" with 3 trials, followed by "ADC Therapeutics S.A." with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored and "Astellas Pharma Inc" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Norton Cancer Institute, St Matthews Campus" #1 collaborator was "Eisai Inc." with 2 trials as a collaborator, "Clinipace Worldwide" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Norton Cancer Institute, St Matthews Campus" are "Acute Myeloid Leukemia" (4 trials), "Triple Negative Breast Cancer" (3 trials), "Carcinoma, Renal Cell" (2 trials), "Diffuse Large B-Cell Lymphoma" (2 trials) and "Follicular Lymphoma" (2 trials). Many other conditions were trialed in "Norton Cancer Institute, St Matthews Campus" in a lesser frequency.

Most popular intervention types in "Norton Cancer Institute, St Matthews Campus" are "Drug" (24 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Azacitidine" (3 trials), "Placebo" (3 trials), "Belzutifan" (2 trials), "Carboplatin" (2 trials) and "Gemcitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Norton Cancer Institute, St Matthews Campus" are 23 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Norton Cancer Institute, St Matthews Campus". undefined are not yet recruiting, 9 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Norton Cancer Institute, St Matthews Campus, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Norton Cancer Institute, St Matthews Campus, 7 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".